Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mayes

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
British Journal of Cancer|June 1, 1996
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposideT Asano, L A Zwelling, T An, et al.
Transplantation Proceedings|December 31, 2003
Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unitA Aggarwal, J P Ong, M Goormastic, et al.
Cancer Communications|January 1, 1990
A restriction fragment length polymorphism for human topoisomerase II: possible relationship to drug-resistanceL A Zwelling, J Mayes, K Deisseroth, et al.
International Journal of Cancer|April 1, 1991
A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistanceB T Hill, R D Whelan, L K Hosking, et al.
Hepatology (Baltimore, Md.)|October 27, 1997
A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejectionD Barnes, D Talenti, G Cammell, et al.
Transplantation Proceedings|February 1, 1987
Increased incidence of immediate function after cadaveric kidney transplantation resulting from lidocaine pretreatment of the donorW Rowinski, A O Gaber, A Chmura, et al.
Biochemistry|April 23, 1991
Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actionsL A Zwelling, J Mayes, M Hinds, et al.
The Journal of Biological Chemistry|October 5, 1989
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase IIL A Zwelling, M Hinds, D Chan, et al.
Journal of the National Cancer Institute|October 3, 1990
HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase IIL A Zwelling, M L Slovak, J H Doroshow, et al.
Abdominal Radiology (New York)|June 27, 2025
Improving radiology reporting accuracy: use of GPT-4 to reduce errors in reportsConnor J Mayes, Chloe Reyes, Mia E Truman, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
British Journal of Cancer|June 1, 1996
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposideT Asano, L A Zwelling, T An, et al.
Transplantation Proceedings|December 31, 2003
Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unitA Aggarwal, J P Ong, M Goormastic, et al.
Cancer Communications|January 1, 1990
A restriction fragment length polymorphism for human topoisomerase II: possible relationship to drug-resistanceL A Zwelling, J Mayes, K Deisseroth, et al.
International Journal of Cancer|April 1, 1991
A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistanceB T Hill, R D Whelan, L K Hosking, et al.
Hepatology (Baltimore, Md.)|October 27, 1997
A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejectionD Barnes, D Talenti, G Cammell, et al.
Transplantation Proceedings|February 1, 1987
Increased incidence of immediate function after cadaveric kidney transplantation resulting from lidocaine pretreatment of the donorW Rowinski, A O Gaber, A Chmura, et al.
Biochemistry|April 23, 1991
Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actionsL A Zwelling, J Mayes, M Hinds, et al.
The Journal of Biological Chemistry|October 5, 1989
Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase IIL A Zwelling, M Hinds, D Chan, et al.
Journal of the National Cancer Institute|October 3, 1990
HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase IIL A Zwelling, M L Slovak, J H Doroshow, et al.
Abdominal Radiology (New York)|June 27, 2025
Improving radiology reporting accuracy: use of GPT-4 to reduce errors in reportsConnor J Mayes, Chloe Reyes, Mia E Truman, et al.
Pageof 6